Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dilsher Dhoot, MD
California Retina Consultants (CRC) - Santa Barbara
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
97 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro Privado de Ojos
Buenos Aires, Argentina
- Charles Research Center (centro Oftalmologico Dr. Charles S.A)
Buenos Aires, Argentina
- Organización Médica de Investigación (omi)
Buenos Aires, Argentina
- Buenos Aires Macula
Caba, Argentina
- Fundacion Zambrano - Cirugia Ocular
Caba, Argentina
- Instituto Oftalmologico de Buenos Aires Sa - Oftalmos
Caba, Argentina
- Fundacion Jorge Zambrano Para la Investigacion, Diagnostico Y Tratamiento de Las Enfermedades Oculares
Ciudad Autonoma de Buenos Aire, Argentina
- Centro Vision S.A.
Mendoza, Argentina
- Oftar Mendoza Srl Centro Privado de Oftalmologia
Mendoza, Argentina
- Laser Vision Group
Rosario, Argentina
- Albury Eye Clinic
Albury, New South Wales, Australia
- Marsden Eye Specialists (mes) - Parramatta
Parramatta, New South Wales, Australia
- Emanuelli Research and Development Center, Llc
Arecibo, Puerto Rico
- Associated Retina Consultant
Gilbert, Arizona, United States
- Associated Retina Consultants, Ltd.
Phoenix, Arizona, United States
- Retinal Research Institute, Llc
Phoenix, Arizona, United States
- Retina Macula Institute of Arizona
Scottsdale, Arizona, United States
- California Retina Consultants
Bakersfield, California, United States
- the Retina Partners
Encino, California, United States
- Retina Consultants of Orange County
Fullerton, California, United States
- Atlantis Eyecare
Huntington Beach, California, United States
- Salehi Retina Institute, Inc., Dba Retina Associates of Southern California
Huntington Beach, California, United States
- Kaiser Permanente Division of Research
Oakland, California, United States
- California Retina Consultants
Oxnard, California, United States
- Stanford Health Care - Byers Eye Institute
Palo Alto, California, United States
- Stanford University School of Medicine, Byers Eye Institute
Palo Alto, California, United States
- California Eye Specialists Medical Group, Inc
Pasadena, California, United States
- Retinal Consultants Medical Group
Sacramento, California, United States
- Orange County Retina Medical Group
Santa Ana, California, United States
- California Retina Consultants
Santa Barbara, California, United States
- Macula Retina Vitreous Research Institute
Torrance, California, United States
- Bay Area Retina Associates
Walnut Creek, California, United States
- Retina Consultants of Southern Colorado
Colorado Springs, Colorado, United States
- Rsc Research, Llc
Denver, Colorado, United States
- Colorado Retina Associates
Lakewood, Colorado, United States
- Retina Consultants, P.C
Manchester, Connecticut, United States
- Retina Group of New England
Waterford, Connecticut, United States
- Advanced Research Llc.
Deerfield Beach, Florida, United States
- Rand Eye Institute
Deerfield Beach, Florida, United States
- Retina Group of Florida
Fort Lauderdale, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Nov 2024
- Primary completion
- 8 Jan 2027
- Completion
- 8 Jan 2027
- Last update posted
- 17 Jun 2025
- Registered enrollment
- 825
- Registry id
- NCT06495918
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.